<?xml version="1.0" encoding="UTF-8"?>
<urlset
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9
		http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
	<url>
		<loc>https://traderxreport.com</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/about/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/authors/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/contribute/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/contact/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/conferences-and-papers/call-for-papers-the-eighth-annual-ip-mosaic-conference/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/conferences-and-papers/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/traderx/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/working-with-the-ministerial-decision-on-trips/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/covid-19/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/trade-policy/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/trips/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/trips-flexibilities/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/praharsh-gour/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/ministerial-decision-tripped-the-waiver/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/shirin-syed/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/right-to-health/intellectual-property-law-and-access-to-medicines-named-one-of-the-best-new-intellectual-property-books-by-bookauthority/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/right-to-health/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/srividhyaragavan/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/omicron-requires-trips-waiver-vaccine/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/vaccines/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/waive-ip-rights-save-lives/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/right-to-health/human-rights-and-intellectual-property-rights/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trips/book-launch-intellectual-property-law-and-access-to-medicines-trips-agreement-health-and-pharmaceuticals/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/all/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/patents/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/michealpalmedo/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/patents/increasing-access-to-medicines-in-black-communities-by-taking-advantage-of-doha-flexibilities/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/myeshia-shelby/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/excerpts-from-the-webinar-accelerating-the-global-vaccine-roll-out-against-covid-19-legal-production-and-logistical-measures/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/right-to-health/expand-the-study-of-intellectual-property-rights/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/the-overlooked-role-of-copyright-in-securing-vaccine-distribution-equity/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/doris-estelle-long/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/webinar-accelerating-the-global-vaccine-roll-out-against-covid-19-legal-production-and-logistical-measures/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trade-policy/promotion-of-trips-plus-intellectual-property-provisions-through-the-special-301-review-how-did-it-change-during-the-covid-19-pandemic/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/data-exclusivities/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/intellectual-property-law-and-access-to-medicines-trips-agreement-health-and-pharmaceuticals/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/indias-vaccination-policy-and-the-covid-19-second-wave-lessons-for-the-world/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/varsha-rajesh/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trips/an-open-letter-to-the-united-states-trade-representative-on-the-trips-waiver/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/vaccines/re-calibrating-covid-diplomacy/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/2021-a-changed-ip-landscape-for-defeating-covid-19/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/the-under-appreciated-virtue-of-transparency-in-combatting-covid-19/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/page/2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/page/3/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/jonathankimball/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/sonalsingh/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/privacy-policy/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/terms-and-conditions/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/cookies-and-tracking-technologies-policy/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/california-consumer-privacy-act-disclosures/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/aarvisingh/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/bhavik-shukla/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/joshua-d-sarnoff/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/juliaschroeder/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/lisaadunner/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/mustafarajkotwala/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/sahkshichandna/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/vidisha-singh/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/covid-19/page/2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/covid-19/page/3/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trips/coronavirus-restoring-trade-access-to-healthcare-as-the-solution/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/trips/page/2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/trips/page/3/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trips-flexibilities/beyond-data-exclusivities-redefining-access-to-necessary-data-in-the-era-of-covid-19/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trips-flexibilities/getting-serious-about-grey-market-imports-in-the-fight-against-covid-19/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/patent-pools/patent-pools-an-attempt-to-reinforce-the-status-quo-and-private-ordering/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/patent-pools/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/voluntary-licenses/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/patents/ip-barriers-in-tackling-covid-19-anything-in-trips-to-help-out/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/right-to-health/the-elixir-of-faith-and-deceit/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/deceptive-claims/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trips/the-india-south-africa-proposal-strengths-weaknesses/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/tamu/executive-education-program-on-health-pharmaceuticals-and-intellectual-property/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/tamu/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/data-exclusivities/is-it-time-to-do-away-with-data-exclusivity/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/ipab/indias-ipab-denies-access-to-a-leukemia-medication-in-an-unsubstantiated-ipab-order-and-creates-uncertainty/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/ipab/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/covid-19-should-change-the-u-s-posture-on-global-access-to-medication/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/srividhyaragavan/page/2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/assuring-social-justice-for-access-to-covid-19-vaccines-part-ii-fixing-the-broken-supply-chain-through-information/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/assuring-social-justice-for-access-to-covid-19-vaccines-part-i-fixing-the-broken-disclosure-system/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trips/patents-and-trade-opportunities-and-challenges-in-the-global-healthcare-market/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/patent-pools/the-role-of-the-medicines-patent-pool-mpp-in-the-context-of-the-global-access-to-medicines-movement/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/patents/page/2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/compelling-reasonable-access-to-covid-19-treatments-under-the-international-patent-system/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/making-sure-patent-rights-create-space-for-rd-against-the-corona-virus-covid-19/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/experimental-use/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/author/doris-estelle-long/page/2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/data-exclusivities/data-exclusivity-and-trips-flexibilities-going-back-to-the-basics/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/data-exclusivities/drug-exclusivities-in-the-us-is-it-justified-part-2-of-2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/patents/drug-exclusivities-in-the-us-is-it-justified-part-1-of-2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/stopping-the-spread-of-counterfeit-medicine-in-the-age-of-covid-19/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/trips-covid-19-and-the-right-to-repair-and-produce-needed-medical-products-in-emergencies-part-2-of-2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/exhaustion/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/trips-covid-19-and-the-right-to-repair-and-produce-needed-medical-products-in-emergencies-part-1-of-2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/patents/compulsory-licensing-or-patent-pools-what-is-the-intellectual-property-answer-to-covid-19/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/covid-19-throws-harsh-spotlight-on-the-human-cost-of-misguided-international-trade-ip-policies/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/category/covid-19/page/1/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/trips/patent-pools-an-attempt-to-reinforce-the-status-quo-and-private-ordering/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/patents/drug-exclusivities-in-the-us-is-it-justified-part-2-of-2/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/covid-19/webinar-accelerating-the-global-vaccine-roll-out-against-covid-19-legal-production-and-logistical-measures/hss_channel-tw-154269785/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/patents/ip-barriers-in-tackling-covid-19-anything-in-trips-to-help-out/_FB_PRIVATE_TRACKING_-{-loggedout_browser_id---247411d07242fc95c5de8c0e9215f87861d4ac79-}/</loc>
	</url>
	<url>
		<loc>https://traderxreport.com/RIGHT-TO-HEALTH/EXPAND-THE-STUDY-OF-INTELLECTUAL-PROPERTY-RIGHTS/</loc>
	</url>
</urlset>